These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 18441340)
1. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645 [TBL] [Abstract][Full Text] [Related]
3. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]. Mei JZ; Guo KY; Wei HM; Song CY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663 [TBL] [Abstract][Full Text] [Related]
4. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809 [TBL] [Abstract][Full Text] [Related]
5. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
6. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
7. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Park MJ; Bae JH; Chung JS; Kim SH; Kang CD Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
9. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
10. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762 [TBL] [Abstract][Full Text] [Related]
11. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]. Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317 [TBL] [Abstract][Full Text] [Related]
14. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells. Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485 [TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980 [TBL] [Abstract][Full Text] [Related]
16. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain. Wittenbrink M; Spreu J; Steinle A Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970 [TBL] [Abstract][Full Text] [Related]
17. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
18. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell. Bae DS; Hwang YK; Lee JK Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008 [TBL] [Abstract][Full Text] [Related]
19. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537 [TBL] [Abstract][Full Text] [Related]